Innate Pharma SA cash flow statement IPHYF
Annual
Quarterly
No matching figures were found for this statement.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IPHA (Nasdaq), IPHYF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Marseille
- SEC filer status
- Accelerated filer
- SEC CIK
- 1598599
- Former names
- Innate Pharma, SA (until Jan 31, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.